Orr Jeremy E, Chen Kenneth, Vaida Florin, Schmickl Christopher N, Laverty Chamindra G, Ravits John, Lesser Daniel, Bhattacharjee Rakesh, Malhotra Atul, Owens Robert L
Division of Pulmonary, Critical Care, and Sleep Medicine, UC San Diego, San Diego, CA, USA.
School of Public Health, UC San Diego, San Diego, CA, USA.
ERJ Open Res. 2023 Sep 25;9(5). doi: 10.1183/23120541.00163-2023. eCollection 2023 Sep.
Patients with neuromuscular disease are often treated with home noninvasive ventilation (NIV) with devices capable of remote patient monitoring. We sought to determine whether long-term NIV data could provide insight into the effectiveness of ventilation over time.
We abstracted available longitudinal data for adults with neuromuscular disease in monthly increments from first available to most recent. Generalised linear mixed-effects modelling with subject-level random effects was used to evaluate trajectories over time.
1799 months of data across 85 individuals (median age 61, interquartile range (IQR) 46-71 years; 44% female; 49% amyotrophic lateral sclerosis (ALS)) were analysed, with a median (IQR) of 17 (8-35) months per individual. Over time, tidal volume increased and respiratory rate decreased. Dynamic respiratory system compliance decreased, accompanied by increased pressure support. Compared to volume-assured mode, fixed-pressure modes were associated with lower initial tidal volume, higher respiratory rate and lower pressures, which did not fully equalise with volume-assured mode over time. Compared with non-ALS patients, those with ALS had lower initial pressure support, but faster increases in pressure support over time, and ALS was associated wtih a more robust increase in respiratory rate in response to low tidal volume. Nonsurvivors did not differ from survivors in ventilatory trajectories over time, but did exhibit decreasing NIV use prior to death, in contrast with stable use in survivors.
NIV keeps breathing patterns stable over time, but support needs are dynamic and influenced by diagnosis and ventilation mode. Mortality is preceded by decreased NIV use rather than inadequate support during use.
神经肌肉疾病患者常在家中使用具备远程患者监测功能的设备进行无创通气(NIV)治疗。我们试图确定长期NIV数据能否为随时间推移的通气有效性提供见解。
我们按月增量提取了成年神经肌肉疾病患者从首次可获得数据到最近数据的可用纵向数据。使用具有个体水平随机效应的广义线性混合效应模型来评估随时间的轨迹。
分析了85名个体(中位年龄61岁,四分位间距(IQR)46 - 71岁;44%为女性;49%为肌萎缩侧索硬化症(ALS))的1799个月数据,每个个体的中位(IQR)时间为17(8 - 35)个月。随着时间推移,潮气量增加,呼吸频率降低。动态呼吸系统顺应性降低,同时压力支持增加。与容量保证模式相比,固定压力模式的初始潮气量较低、呼吸频率较高且压力较低,随着时间推移其压力未能与容量保证模式完全平衡。与非ALS患者相比,ALS患者的初始压力支持较低,但随着时间推移压力支持增加更快,并且ALS与因低潮气量导致的呼吸频率更强劲增加相关。非幸存者与幸存者在通气轨迹随时间变化方面无差异,但在死亡前NIV使用呈下降趋势,而幸存者的使用情况稳定。
NIV可使呼吸模式随时间保持稳定,但支持需求是动态的,且受诊断和通气模式影响。死亡前NIV使用减少,而非使用期间支持不足。